Literature DB >> 15670077

Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002.

Tom K H Butler1, John J Males, Lyon P Robinson, Alfred W Wechsler, Gerard L Sutton, Joanna Cheng, Peter Taylor, Kathleen McClellan.   

Abstract

AIM: To assess the incidence and risk factors for Acanthamoeba keratitis (AK), the diagnostic interval, and the efficacy and outcome of current treatment among the population of New South Wales, Australia.
METHODS: A retrospective review was carried out of all cases of AK treated at the Sydney Eye Hospital between January 1997 and December 2002.
RESULTS: Twenty patients were identified with a mean follow up of 24.8 +/- 21.5 months. Acanthamoeba keratitis constitutes 4.7% of severe infective keratitis treated at Sydney Eye Hospital. The mean interval from first presentation to diagnosis was 26.6 +/- 35.1 days overall; 17.2 +/- 33.1 days for those presenting directly to our unit (69% being diagnosed within 72 h of presentation), and 44.1 +/- 34.0 days for those first presenting elsewhere. Of those with a diagnostic delay >1 month, 57% had been mistakenly diagnosed with Herpes simplex keratitis. Sixteen (80%) wore contact lenses, and eight (40%) had additional risk factors including poor lens hygiene. Complications occurred in 16 (80%), with seven (35%) requiring surgical intervention. Visual acuity improved in 18 (90%), worsened in two patients (10%), and 75% achieved 6/12 or better at last follow up.
CONCLUSIONS: Acanthamoeba keratitis is a rare infection, and contact lens wear remains the commonest association, with poor hygiene constituting significant additional risk. The visual outcome has improved with the availability of effective amoebicidal agents, but patients with a diagnostic delay and non-contact lens wearers are at increased risk of recurrent disease. A high index of clinical suspicion remains the most effective strategy in implementing early treatment, and enabling a favourable outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670077     DOI: 10.1111/j.1442-9071.2004.00911.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  18 in total

Review 1.  Medical interventions for acanthamoeba keratitis.

Authors:  Majed Alkharashi; Kristina Lindsley; Hua Andrew Law; Shameema Sikder
Journal:  Cochrane Database Syst Rev       Date:  2015-02-24

2.  Contact lens compliance among a group of young, university-based lens users in South India.

Authors:  Babu Noushad; Yeshwant Saoji; Premjit Bhakat; Jyothi Thomas
Journal:  Australas Med J       Date:  2012-03-31

3.  Visual outcome in Japanese patients with Acanthamoeba keratitis.

Authors:  K Yamazoe; Y Yamamoto; S Shimazaki-Den; J Shimazaki
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

4.  Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of Acanthamoeba keratitis: a histological study.

Authors:  Lei Shi; Tobias Hager; Fabian Norbert Fries; Loay Daas; Leonard Holbach; Carmen Hofmann-Rummelt; Elena Zemova; Berthold Seitz; Nóra Szentmáry
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

Review 5.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Practice patterns and opinions in the treatment of acanthamoeba keratitis.

Authors:  Catherine E Oldenburg; Nisha R Acharya; Elmer Y Tu; Michael E Zegans; Mark J Mannis; Bruce D Gaynor; John P Whitcher; Thomas M Lietman; Jeremy D Keenan
Journal:  Cornea       Date:  2011-12       Impact factor: 2.651

7.  Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital.

Authors:  S Z Tan; A Walkden; L Au; C Fullwood; A Hamilton; A Qamruddin; M Armstrong; A K Brahma; F Carley
Journal:  Eye (Lond)       Date:  2017-04-28       Impact factor: 3.775

8.  Comparison of UVA- and UVA/riboflavin-induced growth inhibition of Acanthamoeba castellanii.

Authors:  Karim Makdoumi; Anders Bäckman; Jes Mortensen; Anders Magnuson; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-19       Impact factor: 3.117

9.  Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment.

Authors:  Weiyun Shi; Mingna Liu; Hua Gao; Suxia Li; Lixin Xie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-09       Impact factor: 3.117

10.  FLASH: A Novel Tool to Identify Vision-Threating Eye Emergencies.

Authors:  Neil Jairath; Patrick Commiskey; Ariane Kaplan; Yannis M Paulus
Journal:  Int J Ophthalmic Res       Date:  2020-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.